FKBP12 PROTAC dTAG-7 (dTAG-7) is a heterobifunctional PROTAC degrader designed to selectively induce degradation of FKBP12^F36V-tagged proteins. It functions by simultaneously engaging the FKBP12^F36V target and the E3 ubiquitin ligase Cereblon (CRBN), facilitating formation of a ternary complex and promoting ubiquitination and subsequent degradation through the ubiquitin–proteasome system. dTAG-7 can be used as a chemical biology tool for rapid and selective degradation of engineered target proteins and for studying protein function.
The chemical name of FKBP12 PROTAC dTAG-7 is (1R)-3-(3,4-dimethoxyphenyl)-1-(2-((19-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)-2,18-dioxo-7,10,13-trioxa-3,17-diazanonadecyl)oxy)phenyl)propyl (2S)-1-((S)-2-(3,4,5-trimethoxyphenyl)butanoyl)piperidine-2-carboxylate. FKBP12 PROTAC dTAG-7 has a CAS No. of 2064175-32-0, a molecular formula of C₆₃H₇₉N₅O₁₉, and a molecular weight of 1210.32 g/mol.
FKBP12 PROTAC dTAG-7 is suitable for research applications involving targeted protein degradation, PROTAC technology, FKBP12^F36V degrader systems, CRBN-mediated degradation, and functional studies of engineered target proteins. The dTAG system has been used to study degradation of proteins including BRD4, HDAC1, EZH2, MYC, PLK1, and KRAS^G12V. For research use only.
关键字： FKBP12F36V degrader;BRD4 degradation;HDAC1 degradation;EZH2 degradation;MYC degradation;
杭州埃米尔生物技术有限公司位于浙江省杭州市钱塘区下沙街道安和药谷，立足杭州生物医药产业集聚区位优势，专注深耕ADC/XDC 生物偶联技术研发服务、医药小分子中间体定制合成两大核心业务，是聚焦抗体偶联药物上下游研发配套的专业化生物技术初创企业，面向药企、CRO 公司、高校科研院所提供从工艺开发、样品合成到质控分析的一站式技术外包解决方案。